Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

SELL
$4.89 - $12.27 $488,999 - $1.23 Million
-100,000 Reduced 7.5%
1,233,000 $6.05 Million
Q3 2022

Nov 14, 2022

BUY
$8.24 - $12.56 $1.24 Million - $1.88 Million
150,000 Added 12.68%
1,333,000 $12.5 Million
Q1 2022

May 16, 2022

BUY
$9.94 - $12.65 $2.98 Million - $3.8 Million
300,000 Added 33.98%
1,183,000 $14.4 Million
Q4 2021

Feb 14, 2022

BUY
$11.99 - $18.14 $2.01 Million - $3.04 Million
167,316 Added 23.38%
883,000 $10.8 Million
Q3 2021

Nov 15, 2021

BUY
$11.55 - $16.06 $3.27 Million - $4.55 Million
283,506 Added 65.6%
715,684 $11.1 Million
Q2 2021

Aug 16, 2021

SELL
$12.38 - $29.19 $3.64 Million - $8.59 Million
-294,405 Reduced 40.52%
432,178 $6.17 Million
Q1 2021

May 17, 2021

BUY
$15.07 - $21.71 $1.51 Million - $2.17 Million
100,000 Added 15.96%
726,583 $15.8 Million
Q2 2020

Aug 14, 2020

BUY
$12.39 - $17.33 $1.79 Million - $2.51 Million
144,700 Added 30.03%
626,583 $10.7 Million
Q1 2020

May 15, 2020

BUY
$9.12 - $17.78 $94,008 - $183,276
10,308 Added 2.19%
481,883 $6.37 Million
Q4 2019

Feb 14, 2020

BUY
$16.11 - $25.98 $3.06 Million - $4.93 Million
189,767 Added 67.34%
471,575 $7.6 Million
Q3 2019

Nov 14, 2019

BUY
$18.28 - $26.91 $1.49 Million - $2.19 Million
81,308 Added 40.55%
281,808 $5.15 Million
Q2 2019

Aug 14, 2019

BUY
$17.68 - $21.57 $3.54 Million - $4.32 Million
200,500 New
200,500 $4.31 Million

Others Institutions Holding CARA

About Cara Therapeutics, Inc.


  • Ticker CARA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,725,900
  • Market Cap $14M
  • Description
  • Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...
More about CARA
Track This Portfolio

Track Kingdon Capital Management, L.L.C. Portfolio

Follow Kingdon Capital Management, L.L.C. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kingdon Capital Management, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Kingdon Capital Management, L.L.C. with notifications on news.